These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16447768)

  • 1. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
    Aoki M; Takahashi T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.
    Poudel BH; Fletcher S; Wilton SD; Aung-Htut M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
    Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
    Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile.
    Belhassen I; Laroussi S; Sakka S; Rekik S; Lahkim L; Dammak M; Authier FJ; Mhiri C
    Neuromuscul Disord; 2023 Oct; 33(10):718-727. PubMed ID: 37716854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.
    Anwar S; Yokota T
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miyoshi myopathy associated with spine rigidity and multiple contractures: a case report.
    Bardakov SN; Titova AA; Nikitin SS; Nikitins V; Sokolova MO; Tsargush VA; Yuhno EA; Vetrovoj OV; Carlier PG; Sofronova YV; Isaev АА; Deev RV
    BMC Musculoskelet Disord; 2024 Feb; 25(1):146. PubMed ID: 38365661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Patient With Late-onset Limb-girdle Muscular Dystrophy Type 2B Mimicking Dermatomyositis: A Case Report and Review.
    Kim MJ; Oh YJ; Hong YH; Park SH; Oh JS; Kim MJ; Chae JH; Shin K
    J Rheum Dis; 2021 Apr; 28(2):101-106. PubMed ID: 37476015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B.
    Bittel DC; Sreetama SC; Chandra G; Ziegler R; Nagaraju K; Van der Meulen JH; Jaiswal JK
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy.
    Khodabukus A; Prabhu NK; Roberts T; Buldo M; Detwiler A; Fralish ZD; Kondash ME; Truskey GA; Koves TR; Bursac N
    Adv Sci (Weinh); 2024 Aug; 11(31):e2400188. PubMed ID: 38887849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient management problem.
    Rosenfeld J
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1746-50; discussion 1751-61. PubMed ID: 24305460
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of
    Dastur RS; Gaitonde PS; Kachwala M; Nallamilli BRR; Ankala A; Khadilkar SV; Atchayaram N; Gayathri N; Meena AK; Rufibach L; Shira S; Hegde M
    Ann Indian Acad Neurol; 2017; 20(3):302-308. PubMed ID: 28904466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A female case report of LGMD2B with compound heterozygous mutations of the
    Cao X; Zeng L; Lu Z; Fan J; Tan S; Zhang M; Yin Z
    Front Neurol; 2023; 14():1213090. PubMed ID: 37830096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening of an endemic mutation in the DYSF gene in an isolated, mountainous population in the Republic of Dagestan.
    Bardakov SN; Deev RV; Isaev АА; Khromov-Borisov NN; Kopylov ED; Savchuk МR; Pushkin MS; Presnyakov EV; Magomedova RM; Achmedova PG; Umakhanova ZR; Kaimonov VS; Musatova EV; Blagodatskikh KА; Tveleneva AА; Sofronova YV; Yakovlev IA
    Mol Genet Genomic Med; 2023 Oct; 11(10):e2236. PubMed ID: 37553796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do we diagnose Miyoshi Muscular Dystrophy in the absence of symptoms?
    Sönmez Ö; Kimyon U; Çopur M; Ataş İ; Bavunoğlu I
    Eur J Intern Med; 2024 Jul; ():. PubMed ID: 39019734
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
    Patel NJ; Van Dyke KW; Espinoza LR
    Am J Med Sci; 2017 May; 353(5):484-491. PubMed ID: 28502335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and challenges in diagnosis of dysferlinopathy.
    Fanin M; Angelini C
    Muscle Nerve; 2016 Nov; 54(5):821-835. PubMed ID: 27501525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portrait of Dysferlinopathy: Diagnosis and Development of Therapy.
    Bouchard C; Tremblay JP
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.